Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 34 out of 100. Risk factors

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Abstract Background Alzheimer’s disease and related dementias (ADRD) present a growing challenge in the US and has emerged as a significant health concern in American Indian and Alaska Native (AI/AN) communities. ADRD prevalence and risk factors among AI/AN adults remain poorly understood and plagued by inconsistent findings. This study addressed this knowledge gap by examining the associations of social determinants of health (SDOH) with ADRD between AI/AN and non‐Hispanic White (White) populations. Method AI/AN and a 5% random sample of White adults aged 68 and above enrolled in fee‐for‐service (FFS) Medicare in 2019 were included in this study. We used the 2019 Medicare Beneficiary Summary File to obtain data on beneficiaries’ demographics, chronic conditions, and health coverage. We obtained county‐level data from the 2019 Area Health Resource File and the National Center for Health Statistics. Medicaid eligibility and Part D enrollment were used as proxies for individual‐level SDOH. County‐level measures were defined by the percentage of households with incomes below the federal poverty level, the percentage of adults without a high school degree, and county rurality. Separately for AI/AN and White populations, we calculated crude and age‐adjusted prevalence of ADRD and used logistic regressions to examine associations between ADRD and SDOH, controlling for demographics and chronic conditions. Result Among 111,635 AI/AN and 1,015,809 White Medicare beneficiaries included, the ADRD prevalence was 15.6% (age‐adjusted) and 13.4% respectively (OR = 1.24, 95% CI:1.22, 1.27) (Table 2). After multivariate adjustment, the odds ratio of AI/AN for ADRD was not statistically significant (OR = 1.006, 95% CI: 0.980, 1.033). As shown in the Figure, Medicaid eligibility was associated with a substantially higher odds of ADRD among both AI/AN (OR = 2.38, 95% CI: 2.26, 2.50) and White individuals (OR = 3.23, 95% CI: 3.17, 3.29). Part D enrollment was associated with higher odds of ADRD among AI/AN individuals only while county‐level income and education were associated with higher odds of ADRD among White individuals only. Additionally, rurality was associated with lower odds of ADRD in both populations. Conclusion SDOH are potentially modifiable factors, therefore, a deeper understanding of their effects on ADRD can inform future interventions aimed at reducing ADRD prevalence and disparities.

What this study adds

Evidence grade: Low

The work examines social determinants and prevalence, not treatment, cure, or prevention. Reported effect size: 15.6%; 13.4%; OR = 1.24.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Yang, M., Abdulsalam, R., Adjei‐Boateng, R., Li, L., Manson, S. M., O’Connell, J. M., et al. (2024). Associations between Social Determinants of Health and Alzheimer’s Disease and Related Dementia among American Indian and Alaska Native and White Medicare Beneficiaries. Alzheimer s & Dementia. https://doi.org/10.1002/alz.092107

Vancouver

Yang M, Abdulsalam R, Adjei‐Boateng R, Li L, Manson SM, O’Connell JM, et al. Associations between Social Determinants of Health and Alzheimer’s Disease and Related Dementia among American Indian and Alaska Native and White Medicare Beneficiaries. Alzheimer s & Dementia. 2024. doi:10.1002/alz.092107.

BibTeX

@article{yang2024-415a2d4f,
  author  = {Yang, Manxi and Abdulsalam, Ruqoyat and Adjei‐Boateng, Richard and Li, Lingling and Manson, Spero M. and O’Connell, Joan M. and Jiang, Luohua},
  title   = {{Associations between Social Determinants of Health and Alzheimer’s Disease and Related Dementia among American Indian and Alaska Native and White Medicare Beneficiaries}},
  journal = {Alzheimer s \& Dementia},
  year    = {2024},
  doi     = {10.1002/alz.092107},
  url     = {https://doi.org/10.1002/alz.092107}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that age-adjusted Alzheimer's disease and related dementias prevalence was 15.6% among American Indian and Alaska Native Medicare beneficiaries versus 13.4% among White beneficiaries, but the odds ratio for AI/AN was not statistically significant after multivariate adjustment. The work examines social determinants and prevalence, not treatment, cure, or prevention.

Study details

How this study scored 34/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 34 of 100.34 of 100 points earned66 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2024 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 4 year(s) since 2024
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Luohua Jiang: h-index 35 (OpenAlex, whole career)
Institution's track record 1 / 3 University of California, Irvine: institution h-index 1,195 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 34 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Risk factors from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Risk factors

See all studies in Risk factors →